[Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)]. 1981

P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit

Thirty four children with tuberculous meningitis were treated with rifampicin (mean, 17 mg/kg/day) and isoniazid (mean, 18 mg/kg/day). Fifteen (44%) showed rise in transaminase GOT and GPT values and four cases (11.7%) developed jaundice, hepatomegaly and low prothrombin levels. Rifampicin was removed in only nine of these 15 cases with signs of liver disfunction, but complete normalization of liver function and disappearance of symptoms occurred in all cases even when the treatment was not interrupted. Children are more sensitive to hepatic injury during rifampicin and isoniazid combination therapy than adults. Our results indicate very good prognosis for this hepatopathy and suggest that rifampicin need not be withdrawn in the benign situations. Removal of the rifampicin treatment may delay recovery of serious cases of tuberculous meningitis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006529 Hepatomegaly Enlargement of the liver. Enlarged Liver,Liver, Enlarged
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000637 Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1. Aminotransferase,Aminotransferases,Transaminase
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D014390 Tuberculosis, Meningeal A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9) Meningitis, Tuberculous,TB Meningitis,Tubercular Meningitis,Tuberculosis Meningitis,Tuberculous Hypertrophic Pachymeningitis,Hypertrophic Pachymeningitides, Tuberculous,Hypertrophic Pachymeningitis, Tuberculous,Meningeal Tuberculoses,Meningeal Tuberculosis,Meningitides, Tubercular,Meningitides, Tuberculosis,Meningitides, Tuberculous,Meningitis, Tubercular,Meningitis, Tuberculosis,Pachymeningitides, Tuberculous Hypertrophic,Pachymeningitis, Tuberculous Hypertrophic,TB Meningitides,Tubercular Meningitides,Tuberculoses, Meningeal,Tuberculosis Meningitides,Tuberculous Hypertrophic Pachymeningitides,Tuberculous Meningitides,Tuberculous Meningitis

Related Publications

P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
October 1973, Wiener klinische Wochenschrift,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
January 1985, Revista latinoamericana de microbiologia,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
May 1989, The Journal of pediatrics,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
August 1977, Praxis und Klinik der Pneumologie,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
December 1978, The Journal of tropical medicine and hygiene,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
January 1955, La Presse medicale,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
January 1953, Texas reports on biology and medicine,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
October 1953, Lancet (London, England),
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
May 1975, The Journal of pediatrics,
P Frontera Izquierdo, and L Unceta Aguirre, and M Tomás Vila, and F Calvo Rigual, and D Pérez Tamarit
February 1978, Gastroenterologie clinique et biologique,
Copied contents to your clipboard!